Sunil Jha, MD
Clinical Cardiac Electrophysiology · Memphis, TNNPI 1639122054
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Abbott at 58.6% of the total. Reporting peaked in 2023 at $5,179 and has fallen 78.3% since, to $1,126 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TN, where the typical reported total is $12,690.
Across 297 payments — averaging $48.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Medtronic$4K
- Biosense Webster, Inc.$1K
- Boston Scientific$247
- Philips North America LLC$161
- Impulse Dynamics (USA) Inc.$145
- plus $238 from 5 others
Across 15 payments — averaging $1783.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$19K
- Medtronic$7K
What the payments were for
- Consulting fees$2,34016%
- Speaking & faculty fees$2,00014%
- Travel & lodging$2,72619%
- Food & beverage$7,27350%
- Education$1561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 75 | $8,495 |
| Medtronic(2 entities) | 149 | $4,190 |
| Biosense Webster, Inc. | 58 | $1,018 |
| Boston Scientific | 5 | $247 |
| Philips North America LLC | 2 | $161 |
| Impulse Dynamics (USA) Inc. | 1 | $145 |
| Atricure, Inc. | 1 | $135 |
| Recor Medical Inc | 3 | $56 |
| Pfizer | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CardioMEMS HF System$2,340
- Ensite Cardiac Mapping System$2,000
- AMPLATZER AMULET$1,194
- AVEIR$745
- SYMPLICITY G3$329
- AZURE XT DR MRI SURESCAN$239
- Azure$235
- QDOT MICRO Catheter$164
- Accent Pacemaker$161
- (9124) LM Undivided$146
- OPTIMIZER$145
- Resolute$142
- Quartet CRT Lead$136
- EPI-EASE EPICARDIAL ACCESS SYSTEM$135
- Micra$131
- PROCLAIM$130
- ONYX FRONTIER$128
- ENSITE PRECISION$115
- Carto 3$110
How this compares
$14,495 in reported general payments places this provider in the 50th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 664 | $689,095 |
| EntrestoSacubitril/Valsartan | 139 | $176,210 |
| XareltoRivaroxaban | 143 | $157,059 |
| FarxigaDapagliflozin Propanediol | 74 | $84,189 |
| Metoprolol Succinate | 462 | $6,317 |
| Dofetilide | 20 | $5,396 |
| SotalolSotalol Hcl | 179 | $4,712 |
| Mexiletine Hcl | 18 | $3,787 |
| Amiodarone Hcl | 125 | $3,197 |
| Carvedilol | 266 | $2,817 |
| Flecainide Acetate | 97 | $2,696 |
| Nebivolol Hcl | 36 | $2,368 |
| Potassium Chloride | 98 | $1,883 |
| Losartan Potassium | 168 | $1,675 |
| Metoprolol Tartrate | 124 | $1,542 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $689,095664 claims |
| AstraZenecaFarxiga | $17 | $84,18974 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Memphis
- Ikechukwu IfediliMemphis$76K
- Indranill Basu RayMemphis$74K
- Eric JohnsonMemphis$59K
- Rajesh KabraMemphis$42K
- Yehoshua LevineMemphis$37K
- Karine GuerrierMemphis$7K
- Jeffrey KerlanMemphis$7K
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
- Harish ManyamChattanooga$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.